The Circuitry
THE CIRCUITRYYour one-stop source for all tech news
HOMETODAYNEWSFEEDEVENTS
BOOKMARKS
RSS
© 2026 The Circuitry
About UsSourcesContactCorrectionsPrivacy
  • Today
  • Feed
  • Events
  • Saved
Scroll for more
Verification
VERIFIEDConfidence: HIGH
Source identified
Claims cross-referenced
No discrepancies found
Fact-check summary

BBC, NBC News, Business Insider and others confirm CXMT's July 27 STAR Market debut with ~466-472% surge to ~49 yuan and 3.3T yuan valuation.

Sourcing
1source

via CNBC Tech

CNBC Tech · track record
49Stories
100%Verified
1730d
All sources →
Home/Markets/CXMT jumps 466% in Shanghai debut to eclipse all other China-listed firms
VERIFIEDBy Xavier Rivera· ·2 min read

CXMT jumps 466% in Shanghai debut to eclipse all other China-listed firms

CXMT shares jumped nearly 466% in their Shanghai debut, closing at 49 yuan to reach a 3.3 trillion yuan market cap that exceeds every other China-listed firm. The $8.6 billion IPO haul will support memory wafer manufacturing while the firm commands 7.67% of the worldwide DRAM sector and stands to benefit from Beijing's semiconductor self-reliance campaign.

Source:CNBC Tech
Post
CXMT jumps 466% in Shanghai debut to eclipse all other China-listed firms
TL;DRAI · 60 sec read

CXMT rises 466 percent in its first day of trading on Shanghai's STAR Market, becoming the most valuable China-listed firm at 3.3 trillion yuan after raising 57.92 billion yuan in its IPO. Rising global AI demand has turned the DRAM maker profitable and supports China's push for semiconductor self-sufficiency goals.

Chipmaker Changxin Technology Group, known as CXMT, soared nearly 466% in its first day of trading on Shanghai's STAR Market, becoming the most valuable company listed in China with a market capitalization of roughly 3.3 trillion yuan.

CXMT closes at 49 yuan after raising $8.6 billion. The Hefei-based firm raised 57.92 billion yuan ($8.6 billion) through an IPO priced at 8.66 yuan per share, marking Asia's largest this year. Shares ended the session at 49 yuan on Monday, July 27, 2026, surpassing Industrial and Commercial Bank of China's 2.6 trillion yuan valuation.
The debut follows reports that Apple has started evaluating the firm's DRAM components for handsets sold in China.

CXMT holds 7.67% of the worldwide memory chip sector. Based on fourth-quarter 2025 sales data, the company commanded a 7.67% share of the global DRAM market that year, per its IPO prospectus. DRAM chips power devices from smartphones to servers. The sector is led by Samsung Electronics, SK Hynix, and Micron Technology.
From The CircuitryThe Feed — live briefs across tech, all day.See what’s happening →
The company swings to profit amid AI demand. CXMT recorded an operating profit of 35.43 billion yuan in the first quarter, reversing a 2.83 billion yuan loss from the prior year. This shift reflected rising worldwide computing needs and greater chip allocations from leading producers. The debut follows reports that Apple has started evaluating the firm's DRAM components for handsets sold in China.

Proceeds target memory wafer production and R&D. The company intends to direct most IPO funds toward scaling up memory wafer output and research initiatives to strengthen its technical edge and competitiveness, according to its prospectus. Founded in 2016 by Chairman Zhu Yiming, CXMT held that 7.67% slice of the worldwide memory chip sector in 2025.
Analysts cite limited float and AI self-sufficiency push. Theodore Shou, CEO at Yiyi Capital, told CNBC's "Squawk Box Asia" that such a large gain on debut for a firm of this scale stands out, fueled by a constrained free float and accumulated positive sentiment. Morningstar observed that with artificial intelligence emerging as a matter of national security for China, CXMT stands to gain significantly; local tech giants are expected to accelerate uptake of its products as authorities advance semiconductor independence goals. Shou expressed confidence that the firm will mature into a worldwide leader, while cautioning that enthusiasm around the memory cycle may be approaching a near-term high and that elevated margins will moderate over time.
Why this mattersAI · ~100 words

Tap a lens to see what this story means for you.

Reader-supported
DonateBuy me a coffee →Follow@thecircuitry_ →Follow@thecircuitry.to →

Reader-supported · The Brief

Liked this? The Brief brings you the whole day in tech, verified, every morning. Two minutes, free forever.

HELP US IMPROVE
From The Circuitry

See what’s happening right now

The Feed runs all day — short, verified briefs the moment they break.

Open the Feed →
From The Circuitry

Follow @thecircuitry_

Every story we publish, as it happens. No noise between.

Follow on X ↗On Bluesky ↗

Reader-supported

The Circuitry is a passion project I've always wanted to build, and I love the work behind it.

Running it costs real money. APIs, hosting, time. To keep improving the site and growing this into something useful for everyone, those costs have to be covered.

Any contribution is appreciated. If not, no pressure. Thanks for reading.

Buy me a coffee
IPOSemiconductorsChina Tech
More fromCNBC Tech
  • TSMC profit surges 77% as Arizona spending swells by $100 billion

    Tech · 11d
  • Inflation cools, IBM plunges 25%, Morgan Stanley beats

    Markets · 12d
  • SK Hynix Nasdaq Debut Tests Long-Standing Korea Discount

    Markets · 17d
More inMarkets
  • Seattle startup funding drops 40% amid AI shift

    Markets · 2d
  • Repligen Agrees to Buy BioLife Solutions in $1.5 Billion Deal

    Markets · 4d
  • BitMEX to Shut Down in September

    Markets · 4d
SupportThe Work

The Circuitry is reader-supported. If you find the daily brief useful, you can buy me a coffee to keep it going.

Buy a coffee →
SubscribeCircuitry Brief

Liked this? The Brief brings you the whole day in tech, verified, every morning. Free forever.

MORE IN MARKETS

Seattle startup funding drops 40% amid AI shift

Seattle startup funding dropped about 40% in the first half of 2026 while AI money flowed elsewhere, alongside a court loss for Kalshi, Impinj's 10-year Nasdaq milestone, and a local flip-phone detox trial. The developments highlight shifting venture dynamics, legal hurdles for prediction markets, corporate endurance, and growing interest in reducing smartphone reliance.

Repligen Agrees to Buy BioLife Solutions in $1.5 Billion Deal

Repligen will acquire BioLife Solutions for $1.5 billion, merging two longtime providers of tools for cell and gene therapy and biopreservation. The deal values BioLife shares at $31 each and is slated to close in the fourth quarter pending approvals.

BitMEX to Shut Down in September

BitMEX will close its crypto derivatives exchange in September and has urged users to withdraw funds as soon as possible. The shutdown follows a strategic review and comes after years of regulatory penalties and legal actions against the company and its founders.